Related Experiment Video
Updated: Jan 14, 2026
13:01
Anti-Nuclear Antibody Screening Using HEp-2 Cells
Published on: June 23, 2014
137.1K
[Polyarteritis nodosa]
Étienne Ghrenassia1, Alexis Guedon1, Jérôme Hadjadj1
1Sorbonne Université, service de médecine interne, AP-HP, hôpital Saint-Antoine, Paris, France.
La Revue Du Praticien
|October 23, 2025
Summary
Polyarteritis nodosa is a systemic vasculitis affecting medium-sized vessels, causing stenosis or aneurysms. Prognosis depends on organ involvement, with treatments including steroids and cyclophosphamide for severe cases.
Area of Science:
- Medicine
- Rheumatology
- Pathology
Background:
- Polyarteritis nodosa is a systemic necrotizing vasculitis affecting medium-sized arteries.
- This condition can lead to stenosis or aneurysms in affected vessels.
- Manifestations are diverse, impacting multiple organ systems.
Purpose of the Study:
- To summarize the key aspects of polyarteritis nodosa.
- To outline the clinical presentation and diagnostic considerations.
- To discuss the prognostic factors and therapeutic strategies.
Main Methods:
- Review of existing literature on polyarteritis nodosa.
- Analysis of clinical manifestations, including symptoms and signs.
- Evaluation of prognostic indicators and treatment modalities.
Main Results:
- Clinical features include fever, weight loss, mononeuropathy, myalgias, arthritis, and cutaneous lesions.
- Prognosis is significantly influenced by involvement of the digestive tract, kidneys, heart, and central nervous system.
- Polyarteritis nodosa can be primary or secondary to other conditions like viral infections (Hepatitis B, C, HIV) or genetic factors (ADA2 deficiency).
Conclusions:
- Effective management of polyarteritis nodosa requires prompt diagnosis and tailored treatment.
- Corticosteroids are a cornerstone of therapy, often combined with cyclophosphamide for severe or refractory disease.
- Understanding the diverse etiology and potential complications is crucial for improving patient outcomes.
More Related Videos
Related Concept Videos
01:23Rheumatic Heart Disease I: Introduction
426
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
426
01:30Peripheral Artery Disease I: Introduction
310
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
310
01:24Nephrotic Syndrome I : Introduction
493
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
493
01:22Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
476
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
476
01:25Endocarditis II: Clinical Features of Infective Endocarditis
413
Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
413
01:22Pericarditis I: Introduction
324
Pericarditis is defined as the inflammation of the pericardium, the thin, sac-like membrane surrounding the heart. This condition can cause significant chest pain and other symptoms, often necessitating medical intervention. The pericardium has two layers: the inner visceral layer and the outer parietal layer, separated by a small amount of fluid that reduces friction during heartbeats.Types of PericarditisPericarditis can be classified into several types based on the duration and nature of the...
324